PARTNERSHIP
With 26% of the adult population in the UK suffering from respiratory allergies1, it’s no surprise that allergy symptoms can disrupt daily life and the activities we enjoy. In 2024, a poll of 1,000 allergy suffering UK adults aged 18 and over revealed just how profound this impact is for those allergic to pollen, pets, dust, or mould. Here are some key findings2:
- 44% of adults in the UK now live with at least one allergic condition
- Almost 30% of allergy sufferers have had to change their lifestyles to reduce their allergic reactions
- 49% of people reported suffering from hay fever symptoms
- Up to 57% of adult patients and up to 88% of children with allergic rhinitis have sleep problems
- 16.7 million physician office visits are attributed to allergic rhinitis each year
Let’s be honest living with allergies can be frustrating, when you are managing symptoms like sneezing, nasal congestion, itchy throat and nose, coughing, and itchy or watery eyes. Managing red itchy skin caused by hives (nettle rash) a form of skin allergy, can be equally frustrating. Choosing an antihistamine based on your symptoms can be essential, especially if you want to avoid drowsiness from medication.
This is where Allevia® comes into play. As the multi-award-winning purple allergy brand, Allevia® is committed to helping allergy sufferers regain control over their lives.
Allevia® contains fexofenadine, a second- generation antihistamine. Second-generation antihistamines like Allevia®, were developed to more selectively target H1 receptors – which are responsible for many of the symptoms of allergies3. The discovery of antihistamines that selectively act on H1 receptors, is a major milestone in the history of antihistamine’s in more than 70 years because unlike first- generation antihistamines they effectively target your allergy and have no effect on brain function in most people. 3,4,5
Allevia 120mg tablets provide prescription-strength relief from more than just hay fever. It effectively alleviates year-round allergies, including those caused by pets, dust, and mould.
120mg tablets provide prescription-strength relief from more than just hay fever. It effectively alleviates year-round allergies, including those caused by pets, dust, and mould.
Key benefits:
- Gets to work within 1 hour, allowing you to quickly return to your daily activities.
- One tablet provides relief for 24 hours, making it convenient to incorporate into your dailyroutine.
- Allevia®- does not cause drowsiness in most people, so you can stay alert and focused.
- Maximum Strength with minimal effects on the brain e.g. coordination, or alertness in most people.
- Suitable for adults and children aged 12 and over.
- Gluten & Lactose Free.
Exciting news:
We’ve just launched Allevia®- Hives 180mg tablets, now available at your local pharmacist. This new product offers prescription-strength treatment for skin allergies (chronic Internal idiopathic urticaria), further solidifying Allevia 120mg tablets’ position as the the UK’s first fexofenadine without prescription.
If you often feel held back by your allergies, consider incorporating Allevia® 120mg tablets – into your routine. It can help alleviate a wide range of allergic rhinitis symptoms, including sneezing, itching, a runny or blocked nose, and watery eyes.
For more information and to explore our range of allergy solutions, visit www.alleviaallergy.co.uk.
Take charge of your allergies with Allevia today.
MAT-XU-2501630 (V1.0) May 2025
Allevia 120mg tablets contain fexofenadine. For the symptomatic relief of allergic rhinitis. Allevia Hives 180mg tablets contain fexofenadine. For the symptomatic relief of chronic idiopathic urticaria.
Always read the label.
References
1. Allergy UK Statistics & Gigures, Available online: https://www.allergyuk.org/aboutallergy/statistics-and-figures/ Last accessed May 2025
2. Statistics and Figures – Allergy UK | National Charity. (n.d.). Allergy UK | National Charity. Retrieved May 28, 2025, from https://www.allergyuk.org/about-allergy/statistics-and-figures/
3. (Kuna P, Jurkiewicz D, Czarnecka-Operacz MM, et al. The role and choice criteria of antihistamines in allergymanagement – expert opinion. Postepy Dermatol Alergol. 2016;33(6):397-410.)
3. Farzam K, Sabir S, O’Rourke MC. Antihistamines. [Updated 2022 Jul 15]. In: StatPearls [Internet]. TreasureIsland (FL): StatPearls Publishing; 2022. Available at: https://www.ncbi.nlm.nih.gov/books/NBK538188/ Accessed: March 2023.
3. Simons FE, Simons KJ. H1 antihistamines: current status and future directions. World Allergy Organ J. 2008;1(9):145-55.
